F844-1236 Screening compound: ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H,2H-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)piperidine-4-carboxylate

F844-1236 Screening compound: ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H,2H-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)piperidine-4-carboxylate
F844-1236 Screening compound: ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H,2H-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)piperidine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound F844-1236
ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H,2H-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)piperidine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F844-1236

Molecular Formula

C24H32N6O4 (C24 H32 N6 O4)

Compound Name

ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H,2H-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)piperidine-4-carboxylate

IUPAC name

ethyl 1-(2-{[butyl(methyl)carbamoyl]methyl}-1-oxo-1H2H-[124]triazolo[43-a]quinoxalin-4-yl)piperidine-4-carboxylate

SMILES

CCCCN(C)C(CN(C1=O)N=C2N1c(cccc1)c1N=C2N(CC1)CCC1C(OCC)=O)=O

InChI

InChI=1S/C24H32N6O4/c1-4-6-13-27(3)20(31)16-29-24(33)30-19-10-8-7-9-18(19)25-21(22(30)26-29)28-14-11-17(12-15-28)23(32)34-5-2/h7-10,17H,4-6,11-16H2,1-3H3

InChI Key

AATPKYFDDZEXBA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27199306

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.165

Distribution Coefficient, logD

2.165

Water Solubility, LogSw

-2.46

Polar Surface Area

78.657

Acid Dissociation Constant (pKa)

18.70

Base Dissociation Constant (pKb)

2.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

F844-1236 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with F844-1236 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F844-1236?
Check Price and Availability of F844-1236, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F844-1236 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F844-1236
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F844-1236
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F844-1236 available by request